AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise. The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).
Learn more about the comment process
AMIA responses are arranged by Federal Agency and Congressional Committee.
America’s progress, from vaccines to space exploration, rests on rigorous, unbiased scientific inquiry. AMIA joined with the United Science Alliance, a wide coalition of scientific, academic, and public-health organizations, in sending a letter to the Office of Science and Technology Policy agreeing with the overarching goal of the Executive Order […]
AMIA joined with over 200 organizations, submitted a joint letter urging the DEA to finalize regulations for a special registration process that would permit telemedicine prescribing of controlled substances without requiring in-person visits. The letter emphasizes that delays in finalizing these rules jeopardize access to care for patients relying on […]
AMIA commented supporting NIH's three-stage AI strategy progression from data analytics to autonomous biomedical AI systems. We emphasized AI principles including explainability, fairness, transparency, and accountability. Key recommendations include requiring FAIR data principles for federal grants, mandating explainable AI methods, establishing "algorithmovigilance" for continuous monitoring, and developing comprehensive AI competency […]
AMIA responded to the NIH National Library of Medicine's Request for Information on future biomedical informatics research priorities. The organization addressed three key areas:
(A) Vision for the Future, highlighting unmet needs in multi-modal data integration, temporal health modeling, and precision prevention; key challenges in causal inference, real-time adaptive learning […]
AMIA joins 104 health organizations to urge Congress to protect the U.S. Preventive Services Task Force (USPSTF) from political interference following the Kennedy v. Braidwood ruling. The USPSTF, established in 1984, provides evidence-based preventive care recommendations that insurers must cover at no cost. The letter emphasizes maintaining key structures: 4-year […]
AMIA, along with 66 healthcare organizations urge Congress to restore the cancelled AHRQ Healthcare Extension Service program, which would translate patient-centered research into real-world healthcare delivery, particularly for behavioral health in underserved rural communities. The program was cancelled due to unauthorized HHS reorganization despite strong state applications addressing mental health […]
AMIA urges CMS and ASTP/ONC to advance patient-centered innovation by ensuring comprehensive, computable access to health data through standardized API and integration of patient voices in standards development. Recommendations emphasize digital identity, usability for older adults, and reducing documentation burden. AMIA calls for scalable, interoperable tools, robust privacy protections, and […]
AMIA, along with a coalition of over 80 medical and research organizations, wrote to Congressional leaders on June 10, 2025, expressing urgent concerns about the National Institutes of Health. The letter highlights three critical issues: scientists cannot access legally appropriated research funds despite excellent grant scores; NIH is being restructured […]
AMIA submitted comments to the CMS RFI: Unleashing Prosperity Through Deregulation of the Medicare Program recommending the elimination or significant streamlining of prior authorization (PA) requirements as the primary Medicare deregulation priority. We stand that PA creates substantial administrative burden, with physicians spending 2+ days weekly on approvals, while 80% […]
In response to the National AI R&D Strategic Plan RFI, AMIA calls for embedding healthcare priorities within AI research and development efforts. They advocate for ethical R&D practices grounded in transparency, safety, fairness, and equity. AMIA emphasizes the need for high-quality data, bias mitigation, and interdisciplinary collaboration to guide responsible […]